Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis

Abstract

Background Hearing disorders are reported in thalassemia patients treated with deferoxamine. This study aimed to assess hearing loss in Iranian thalassemia major patients treated with deferoxamine. Methods This review article was designed based on PRISMA guidelines. To review the literature, two researchers studied national and international databases… (More)
DOI: 10.22088/cjim.8.4.239

Topics

7 Figures and Tables

Cite this paper

@inproceedings{Badfar2017HearingLI, title={Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis }, author={Gholamreza Badfar and Akram Mansouri and Masoumeh Shohani and Hamid Reza Karimi and Zahra Khalighi and Shoboo Rahmati and Ali Delpisheh and Yousef Veisani and Ali Asghar Soleymani and Milad Azami}, booktitle={Caspian journal of internal medicine}, year={2017} }